CompaniesArxx Therapeutics

Arxx Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

58

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
Today
NCT05965089
Hover over trial bars to see details

Recent Trials

NCT05965089Lead Sponsor
A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.
PHASE1Completed
58 participants
Started: Apr 25, 2023 · Completed: Jul 31, 2024
Related Companies
Oxitope To Become Calluna
merged